<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedBookArticle><BookDocument><PMID Version="1">30844192</PMID><ArticleIdList><ArticleId IdType="bookaccession">NBK538165</ArticleId></ArticleIdList><Book><Publisher><PublisherName>StatPearls Publishing</PublisherName><PublisherLocation>Treasure Island (FL)</PublisherLocation></Publisher><BookTitle book="statpearls">StatPearls</BookTitle><PubDate><Year>2022</Year><Month>01</Month></PubDate><BeginningDate><Year>2022</Year><Month>01</Month></BeginningDate><Medium>Internet</Medium></Book><ArticleTitle book="statpearls" part="article-17404">Alprazolam</ArticleTitle><Language>eng</Language><AuthorList Type="authors" CompleteYN="Y"><Author ValidYN="Y"><LastName>George</LastName><ForeName>Tobin T.</ForeName><Initials>TT</Initials><AffiliationInfo><Affiliation>University of Medicine and Health Sci</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tripp</LastName><ForeName>Jayson</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>CUSOM/Cape Fear Valley Health Center</Affiliation></AffiliationInfo></Author></AuthorList><PublicationType UI="D000072643">Study Guide</PublicationType><Abstract><AbstractText>Alprazolam, known by various trade names, is the most commonly prescribed psychotropic medication in the United States. Alprazolam is frequently prescribed to manage panic and anxiety disorders. Alprazolam has also been misused for recreational purposes because of its disinhibition, euphoria, and anxiolytic effects. FDA-labeled indications include anxiety disorders and panic disorders with or without agoraphobia. This activity outlines the indications, mechanism of action, administration, dosing, contraindications, warnings, precautions, adverse drug reactions, and toxicity of alprazolam in the clinical setting as relates to the essential points needed by members of an interprofessional team managing the care of patients with mental health disorders.</AbstractText><CopyrightInformation>Copyright © 2022, StatPearls Publishing LLC.</CopyrightInformation></Abstract><Sections><Section><SectionTitle book="statpearls" part="article-17404" sec="article-17404.s1">Continuing Education Activity</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-17404" sec="article-17404.s2">Indications</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-17404" sec="article-17404.s3">Mechanism of Action</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-17404" sec="article-17404.s4">Administration</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-17404" sec="article-17404.s5">Adverse Effects</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-17404" sec="article-17404.s6">Contraindications</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-17404" sec="article-17404.s7">Monitoring</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-17404" sec="article-17404.s8">Toxicity</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-17404" sec="article-17404.s9">Enhancing Healthcare Team Outcomes</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-17404" sec="article-17404.s10">Review Questions</SectionTitle></Section><Section><SectionTitle book="statpearls" part="article-17404" sec="article-17404.s11">References</SectionTitle></Section></Sections><ContributionDate><Year>2022</Year><Month>5</Month><Day>1</Day></ContributionDate><ReferenceList><Reference><Citation>Hedegaard H, Bastian BA, Trinidad JP, Spencer M, Warner M. Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2011-2016. Natl Vital Stat Rep. 2018 Dec;67(9):1-14.</Citation><ArticleIdList><ArticleId IdType="pubmed">30707673</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashton H. Guidelines for the rational use of benzodiazepines. When and what to use. Drugs. 1994 Jul;48(1):25-40.</Citation><ArticleIdList><ArticleId IdType="pubmed">7525193</ArticleId></ArticleIdList></Reference><Reference><Citation>Masiulis S, Desai R, Uchański T, Serna Martin I, Laverty D, Karia D, Malinauskas T, Zivanov J, Pardon E, Kotecha A, Steyaert J, Miller KW, Aricescu AR. GABAA receptor signalling mechanisms revealed by structural pharmacology. Nature. 2019 Jan;565(7740):454-459.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6370056</ArticleId><ArticleId IdType="pubmed">30602790</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibáñez J, González de la Aleja J, Gallego JA, Romero JP, Saíz-Díaz RA, Benito-León J, Rocon E. Effects of alprazolam on cortical activity and tremors in patients with essential tremor. PLoS One. 2014;9(3):e93159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3965529</ArticleId><ArticleId IdType="pubmed">24667763</ArticleId></ArticleIdList></Reference><Reference><Citation>Preuss CV, Kalava A, King KC.  StatPearls [Internet] StatPearls Publishing; Treasure Island (FL): 2021. Aug 31, Prescription of Controlled Substances: Benefits and Risks.</Citation><ArticleIdList><ArticleId IdType="pubmed">30726003</ArticleId></ArticleIdList></Reference><Reference><Citation>Quagliato LA, Freire RC, Nardi AE. Risks and benefits of medications for panic disorder: a comparison of SSRIs and benzodiazepines. Expert Opin Drug Saf. 2018 Mar;17(3):315-324.</Citation><ArticleIdList><ArticleId IdType="pubmed">29357714</ArticleId></ArticleIdList></Reference><Reference><Citation>Ait-Daoud N, Hamby AS, Sharma S, Blevins D. A Review of Alprazolam Use, Misuse, and Withdrawal. J Addict Med. 2018 Jan/Feb;12(1):4-10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5846112</ArticleId><ArticleId IdType="pubmed">28777203</ArticleId></ArticleIdList></Reference><Reference><Citation>Drugs and Lactation Database (LactMed) [Internet] National Library of Medicine (US); Bethesda (MD): 2006. Alprazolam.</Citation><ArticleIdList><ArticleId IdType="pubmed">30000258</ArticleId></ArticleIdList></Reference><Reference><Citation>Guina J, Merrill B. Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives. J Clin Med. 2018 Jan 30;7(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5852433</ArticleId><ArticleId IdType="pubmed">29385731</ArticleId></ArticleIdList></Reference><Reference><Citation>Arvat E, Maccagno B, Ramunni J, Di Vito L, Giordano R, Gianotti L, Broglio F, Camanni F, Ghigo E. The inhibitory effect of alprazolam, a benzodiazepine, overrides the stimulatory effect of metyrapone-induced lack of negative cortisol feedback on corticotroph secretion in humans. J Clin Endocrinol Metab. 1999 Aug;84(8):2611-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">10443648</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto T, Dargan PI, Dines A, Yates C, Heyerdahl F, Hovda KE, Giraudon I, Sedefov R, Wood DM, Euro-DEN Research Group  Concurrent Use of Benzodiazepine by Heroin Users-What Are the Prevalence and the Risks Associated with This Pattern of Use? J Med Toxicol. 2019 Jan;15(1):4-11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6314928</ArticleId><ArticleId IdType="pubmed">30066312</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Xu Z, Wang H, Zhao ZQ, Rao Y. Influence of ethanol on the metabolism of alprazolam. Expert Opin Drug Metab Toxicol. 2018 Jun;14(6):551-559.</Citation><ArticleIdList><ArticleId IdType="pubmed">29848078</ArticleId></ArticleIdList></Reference><Reference><Citation>Navy HJ, Weffald L, Delate T, Patel RJ, Dugan JP. Clinical Pharmacist Intervention to Engage Older Adults in Reducing Use of Alprazolam. Consult Pharm. 2018 Dec 01;33(12):711-722.</Citation><ArticleIdList><ArticleId IdType="pubmed">30545435</ArticleId></ArticleIdList></Reference></ReferenceList></BookDocument><PubmedBookData><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30844192</ArticleId></ArticleIdList></PubmedBookData></PubmedBookArticle></PubmedArticleSet>
